Cannabis Drugs Market Size, Share, Growth & Industry Analysis, By Product (Capsules, Concentrates, Edibles, and Others), By Application (Chronic Pain, Migraine, Cancer, Arthritis, Parkinson's Disease, Muscle Spasms, Depression and Anxiety, and Others), By End User, and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL CANNABIS DRUGS MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL CANNABIS DRUGS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL CANNABIS DRUGS MARKET, BY PRODUCT
6.1 Overview
6.2 Capsules
6.3 Concentrates
6.4 Edibles
6.5 Others

7 GLOBAL CANNABIS DRUGS MARKET, BY APPLICATION
7.1 Overview
7.2 Chronic Pain
7.3 Migraine
7.4 Cancer
7.5 Arthritis
7.6 Parkinson's Disease
7.7 Muscle spasms
7.8 Depression and Anxiety
7.9 Others

8 GLOBAL CANNABIS DRUGS MARKET, BY END USER
8.1 Overview
8.2 Pharmaceutical Industries
8.3 Hospitals
8.4 Research and Development Centers
8.5 Homecare Settings and Rehab Centers

9 GLOBAL CANNABIS DRUGS MARKET, BY GEOGRAPHY
9.1 Overview

10 NORTH AMERICA 
10.1 U.S.
10.2 Canada
10.3 Mexico

11 EUROPE 
11.1 Germany
11.2 U.K.
11.3 France
11.4 Italy
11.5 Spain
11.6 Russia
11.7 Rest of Europe

12 ASIA-PACIFIC 
12.1 China
12.2 Japan
12.3 India
12.4 South Korea
12.5 Rest of Asia-Pacific

13 MIDDLE EAST & AFRICA 
13.1 GCC
13.2 South Africa
13.3 North Africa
13.4 Rest of Middle East & Africa

14 LATIN AMERICA 
14.1 Brazil
14.2 Argentina
14.3 Rest of South America

15 GLOBAL CANNABIS DRUGS MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Type Footprint

16 COMPANY PROFILES
16.1 Canopy Growth Corporation
16.1.1 Key Facts
16.1.2 Financial Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.1.5 Winning Imperatives
16.1.6 Current Focus & Strategies
16.1.7 Threat from competition
16.1.8 SWOT Analysis
16.2 Tilray Inc.
16.2.1 Key Facts
16.2.2 Financial Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.2.5 Winning Imperatives
16.2.6 Current Focus & Strategies
16.2.7 Threat from competition
16.2.8 SWOT Analysis
16.3 Cronos Group Inc.
16.3.1 Key Facts
16.3.2 Financial Overview
16.3.3 Product Benchmarking
16.3.4 Recent Developments
16.3.5 Winning Imperatives
16.3.6 Current Focus & Strategies
16.3.7 Threat from competition
16.3.8 SWOT Analysis
16.4 Jazz Pharmaceuticals plc
16.4.1 Key Facts
16.4.2 Financial Overview
16.4.3 Product Benchmarking
16.4.4 Recent Developments
16.4.5 Winning Imperatives
16.4.6 Current Focus & Strategies
16.4.7 Threat from competition
16.4.8 SWOT Analysis
16.5 The Cannabist Company
16.5.1 Key Facts
16.5.2 Financial Overview
16.5.3 Product Benchmarking
16.5.4 Recent Developments
16.5.5 Winning Imperatives
16.5.6 Current Focus & Strategies
16.5.7 Threat from competition
16.5.8 SWOT Analysis
16.6 Curaleaf
16.6.1 Key Facts
16.6.2 Financial Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.7 Green Thumb Industries
16.7.1 Key Facts
16.7.2 Financial Overview
16.7.3 Product Benchmarking
16.7.4 Recent Developments
16.8 IMC Holdings Ltd.
16.8.1 Key Facts
16.8.2 Financial Overview
16.8.3 Product Benchmarking
16.8.4 Recent Developments
16.9 AURORA CANNABIS INC.
16.9.1 Key Facts
16.9.2 Financial Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments
16.10 NIRAS A/S
16.10.1 Key Facts
16.10.2 Financial Overview
16.10.3 Product Benchmarking
16.10.4 Recent Developments

LIST OF TABLES

TABLE 1 Global Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 2 Global Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 3 Global Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 4 Global Cannabis Drugs Market Revenue, By Geography, 2021 - 2031 (USD Million)
TABLE 5 North America Cannabis Drugs Market Revenue, By Country, 2021 - 2031 (USD Million)
TABLE 6 North America Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 7 North America Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 8 North America Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 9 US Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 10 US Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 11 US Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 12 Canada Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 13 Canada Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 14 Canada Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 15 Mexico Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 16 Mexico Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 17 Mexico Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 18 Europe Cannabis Drugs Market Revenue, By Country, 2021 - 2031 (USD Million)
TABLE 19 Europe Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 20 Europe Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 21 Europe Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 22 Germany Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 23 Germany Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 24 Germany Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 25 France Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 26 France Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 27 France Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 28 U.K. Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 29 U.K. Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 30 U.K. Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 31 Spain Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 32 Spain Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 33 Spain Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 34 Italy Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 35 Italy Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 36 Italy Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 37 Russia Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 38 Russia Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 39 Russia Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 40 Rest of Europe Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 41 Rest of Europe Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 42 Rest of Europe Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 43 Asia-Pacific Cannabis Drugs Market Revenue, By Country, 2021 - 2031 (USD Million)
TABLE 44 Asia-Pacific Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 45 Asia-Pacific Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 46 Asia-Pacific Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 47 China Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 48 China Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 49 China Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 50 Japan Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 51 Japan Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 52 Japan Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 53 India Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 54 India Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 55 India Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 56 South Korea Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 57 South Korea Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 58 South Korea Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 59 Rest of Asia-Pacific Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 60 Rest of Asia-Pacific Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 61 Rest of Asia-Pacific Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 62 Middle East and Africa Cannabis Drugs Market Revenue, By Country, 2021 - 2031 (USD Million)
TABLE 63 Middle East and Africa Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 64 Middle East and Africa Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 65 Middle East and Africa Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 66 GCC Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 67 GCC Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 68 GCC Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 69 North Africa Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 70 North Africa Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 71 North Africa Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 72 South Africa Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 73 South Africa Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 74 South Africa Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 75 Rest of Middle East & Africa Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 76 Rest of Middle East & Africa Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 77 Rest of Middle East & Africa Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 78 Latin America Cannabis Drugs Market Revenue, By Country, 2021 - 2031 (USD Million)
TABLE 79 Latin America Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 80 Latin America Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 81 Latin America Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 82 Brazil Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 83 Brazil Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 84 Brazil Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 85 Argentina Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 86 Argentina Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 87 Argentina Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 88 Rest of Latin America Cannabis Drugs Market Revenue, By Product, 2021 - 2031 (USD Million)
TABLE 89 Rest of Latin America Cannabis Drugs Market Revenue, By Application, 2021 - 2031 (USD Million)
TABLE 90 Rest of Latin America Cannabis Drugs Market Revenue, By End User, 2021 - 2031 (USD Million)
TABLE 91 Company Market Ranking
TABLE 92 Regional Footprint
TABLE 93 Product Type Benchmarking
TABLE 94 Recent Developments
TABLE 95 Winning Imperatives

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Cannabis Drugs Market 2021-2031 (USD Million)
FIG. 4 Global Cannabis Drugs Market Geographical Analysis (CAGR %)
FIG. 5 Global Cannabis Drugs Absolute Market Opportunity (USD Million)
FIG. 6 Global Cannabis Drugs Market Attractiveness (USD Million)
FIG. 7 Global Cannabis Drugs Market, By Product, 2021-2031 (USD Million)
FIG. 8 Global Cannabis Drugs Market, By Application, 2021-2031 (USD Million)
FIG. 9 Global Cannabis Drugs Market, By End User, 2021-2031 (USD Million)
FIG. 10 Research Methodology
FIG. 11 Research Process
FIG. 12 Bottom-Up Approach
FIG. 13 Top-Bottom Approach
FIG. 14 Market Dynamics Overview
FIG. 15 Porter's Five Forces Analysis
FIG. 16 Value Chain Analysis
FIG. 17 Macroeconomic Analysis
FIG. 18 Global Cannabis Drugs Market Revenue Share, By Product, 2023 and 2031 (%)
FIG. 19 Global Cannabis Drugs Market Revenue Share, By Application, 2023 and 2031 (%)
FIG. 20 Global Cannabis Drugs Market Revenue Share, By End User, 2023 and 2031 (%)
FIG. 21 Global Cannabis Drugs Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 22 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 23 North America Cannabis Drugs Market Overview Share, By Countries, 2021 - 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 25 Europe Cannabis Drugs Market Overview Share, By Countries, 2021 - 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 27 Asia-Pacific Cannabis Drugs Market Overview Share, By Countries, 2021 - 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 29 Middle East & Africa Cannabis Drugs Market Overview Share, By Countries, 2021 - 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 31 Latin America Cannabis Drugs Market Overview Share, By Countries, 2021 - 2031 (%)
FIG. 32 Key Strategic Development
FIG. 33 Key Facts
FIG. 34 Financial Overview
FIG. 35 SWOT Analysis